Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Panacea Biotec Ltd announces collaboration with Serum Institute of India Pvt. Ltd. and Bilthovan Biologicals B.V.

Posted On: 2018-01-18 00:31:35

Panacea Biotec Ltd. (PBL) is delighted to announce the collaboration with signing of two long term agreements with Serum Institute of India Pvt. Ltd. (511) and Sil's wholly owned subsidiary, Bilthovan Biologicals B.V. (BBIO). Under the collaboration 511 is entitled to manufacture & sell fully liquid Whole cell Pertussis (wP) and Salk based Injectable Polio Vaccine (IPV) based Hexavalent vaccine (DTwPHepB-Hib-IPV) developed & commercialized by Panacea Biotec, a first of its kind in this category.

Under the collaboration, broadly the following will be achieved:-

- Serum Institute of India will ensure supply of IPV bulk to Panacea Biotec, an important constituent of the Hexavalent vaccine, from its wholly owned subsidiary BBIO, a bioengineering and pharmaceutical company, registered in The Netherlands having technology and expertise for making the IPV, earlier possessed by only 3 other vaccine manufacturers in the World.

- In next 2 years both SII and PBL will work together to get this wP-IPV based Hexavalent Vaccine introduced in the National Immunization Program of Government of India and developing countries by working closely with key stakeholders including but not limited to National Governments, World Health Organization (WHO), Global Alliance for Vaccines & Immunization (GAVI), Bill and Melinda Gates Foundation (BMGF) and other United Nation Agencies, etc.

Speaking on the occasion Dr Rajesh Jain, Joint Managing Director, Panacea Biotec said that millions of children in developing countries with an annual birth cohort of approx. 121 Million will get an easy access to a fully liquid Hexavalent vaccine containing six very important antigens to protect against six dreaded diseases i.e. Diphtheria, Tetanus, Pertussis, Hepatitis B, Haemophilus influenza type B & Polio. Dr. Rajesh Jain added that it is the first fully liquid wP-IPV based hexavalent vaccine in the World which Panacea Biotec has developed making India proud under Government of India's Make in India Program and currently being marketed in India under brand name EasySix™.

WHO prequalified IPV is essential to successfully eradicating Polio across the globe, an effort that has already cost $ 20 Billion worldwide. There is a Global Polio Eradication Initiative (GPEI) in place & Global Alliance for Vaccine Initiative (GAVI) has been supporting the program since 2013 having allocated $430 Million till 2018 with an additional donor pledge of $23 Million for 2019. At present GAVI is evaluating IPV under Vaccine Investment Strategy for Global Public Good.

Global demand of IPV/ IPV containing vaccines is estimated to rise significantly from ~100 Million in the year 2020 till supply constraints remain, to 250-350 Million doses every year starting 2022 depending upon a two or three dose schedule as Strategic Advisory Group of Experts (SAGE) on Immunization in April 2017 has recommended at least 2 doses of IPV in the routine Immunization schedule of the countries post OPV withdrawal.

Here it is important to note that there has been a global supply constraint of IPV since early 2015 and only 52% of projected supply had been delivered to UN agencies as a result of which 18 Countries could not introduce IPV in their immunization & 15 had interruptions out of 70 IPV eligible countries approved for GAVI support.

A beaming Mr Adar C. Poonawalla, CE.O. & Executive Director, Serum Institute of India, said, lilt is an historic deal where in two major vaccine Companies in India have come forward to join hands to address unmet needs of both Private & Public Market globally. With the convenience of 'Six in one' it has potential of over 250 million doses in next 3-4 years with a market size of over $1.25 Billion annually."

Mr R K Suri, Senior Advisor, who orchestrated the mega deal between two big Vaccine players said, lilt marks beginning of a new Era in vaccine landscape and heralds a new business model, 'Collaborate yet Compete!'."

Shares of PANACEA BIOTEC LTD. was last trading in BSE at Rs.256.9 as compared to the previous close of Rs. 253.7. The total number of shares traded during the day was 64132 in over 1624 trades.

The stock hit an intraday high of Rs. 264.15 and intraday low of 244.55. The net turnover during the day was Rs. 16561499.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

RBL Bank Ltd - Q1 FY19 Operating review

Pudumjee Industries Ltd calls for board meeting on July 28, 2018

Trigyn Awarded - U.S. Army Picatinny Arsenal - Software Engineering Center Contract

Parag Milk Fods Limited Welcomes Government of India Announcement of 10% Export Subsidy

Edelweiss announces Rs.20,000 million Public Issue of Secured Redeemable NCDs

Sterlite Technologies Ltd Q1 net profit jumps to Rs. 128.48 crores

Bajaj Finance Ltd Q2 consolidated PAT soars to Rs. 835.89 crore

Kotak Mahindra Bank Q1 net profit climbs to Rs. 1574.48 crores

Menon Bearings Ltd Q1 PAT zooms to Rs. 7.19 crore

Integra Engineering India Ltd Q1 net profit at Rs. 1.04 crore

Apollo Tyres Ltd calls for board meeting on Aug 1, 2018

Artson Engineering Ltd receives order of Rs. 28.94 crores

RBL Bank Ltd - Q1 FY19 Performance highlights

NTPC Ltd board to consider quarterly results on July 28, 2018

NIIT launches pioneering Career Programs to match the changing talent requirements of global organizations

NCC Ltd board to announce Q1 results on Aug 10, 2018

Electrotherm India Ltd enters into settlement with IFC

LT Foods Ltd board to approve first quarter results on Aug 13, 2018

JMC Projects India Ltd board to consider Q1 results, stock split

Majesco Ltd board to announce 1st quarter results on Aug 2, 2018

RBL Bank Ltd Q1 PAT rises to Rs. 190.04 crores

Godrej Properties Ltd board to announce Q1 results on Aug 2, 2018

Infosys Foundation Signs MoU with Bangalore Metro to Build & Maintain the Electronics City Metro Station

Lupin receives tentative FDA approval for generic Tadalafil Tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg

Mindtree establishes an endowed faculty scholar position in AI at Stanford University's School of Engineering

ADC India Communications Limited calls for board meeting on Aug 10, 2018

Godawari Power and Ispat Ltd awarded long term coal linkage

Reliance Securities Q1 PBT at Rs. 8 crore

AGC Networks Limited board to approve 1st quarter results on July 31, 2018

Dhanlaxmi Bank Limited board to consider first quarter results on Aug 6, 2018

Hawkins Cookers Ltd calls for board meeting on Aug 7, 2018

Zydus receives final approval from the USFDA for Piroxicam Capsules USP

Akshali Shah, awarded the 'Entrepreneur of the Year in Service Business - FMCG' by Entrepreneur India

MCX takes preventive measures against technical glitches

JK Tyre & Industries Ltd Q1 FY18-19 revenue up at Rs. 2446 crores

Mindtree Reports Strong revenue growth of 6.8% q-o-q and 20.7% y-o-y in USD terms

GHCL announces Q1 FY18-19 Results

Foseco India Ltd board declares 1st interim dividend of Rs. 7 for 2018

Sasken Technologies Limited Q1 FY18-19 Snapshot

Corporation Bank Ltd board to consider preferential issue on July 21, 2018

Raymond Ltd board to announce Q1 results on July 31, 2018

Indian Overseas Bank to receives capital infusion of Rs. 2157 crore

BNK Capital Markets Ltd board to consider 1st quarter results on July 28, 2018

NIIT Technologies Q1FY'19 PAT up 67.4%

GE T&D India Ltd board to announce first quarter results on July 25, 2018

Flex Films launches Web Metalized Surface Inspection System

Sun Pharma Advanced Research Company Ltd calls for board meeting on July 30, 2018

Wockhardt Ltd board to consider Q1 results on Aug 4, 2018

Lemon Tree Hotels Ltd board to approve first quarter results on Aug 13, 2018

Pondy Oxides & Chemicals Ltd board to announce quarterly results on Aug 7, 2018





Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2018